Change in Project Coordinator from Amniotics to Magle Biopharma

Change in Project Coordinator from Amniotics to Magle Biopharma

In October 2024, Magle Group completed a merger with Amniotics. Since then, Magle Group has continued Amniotics’ business operations in the company Magle Biopharma, which is part of the Magle Group suite of companies. Magle Biopharma has become the new project coordinator for the project, with Magle Chemoswed Holding registered as an associate company.